Deny people prophylaxes and therapeutics and guess what happens.
Though most of these are likely patients in with NOT for CoupFlu.
The problem with p's and t's is, they gotta do the same research on them, that everyone demands of vaccines. Can't demand 5 years for one and 2 months for another. The African study which is specifically looking for low-cost p's and t's wasn't promising for some drugs and neither are the McMasters 3-nation studies. But researchers are still trying.
Here's one that is in phase 2/3 trials in the US and Africa you might not have heard about, but until now only 200 study participants so who knows the side effects when one is trying to target a few cells and not all cells:
Red Hill's About RHB-107 (upamostat)
of or with doesnt' really matter if the with makes the original nonlethal complaint deadly; even a broken leg pays the hospital more than a covid isolation admission ;)